ICF has provided regulatory support for various DOJ Drug Enforcement Administration (DEA) regulations, including conducting background research to support policy decisions, helping draft Federal Register preambles and regulatory text, summarizing comments, and developing regulatory economic analyses, small entity analyses, regulatory flexibility analyses, and information collection requests.
ICF has helped DEA translate technical requirements for electronic orders and prescriptions into regulatory language. We conducted the economic analysis for DEA’s electronic ordering rules to estimate the costs of using a public key infrastructure system to sign and validate electronic orders for Schedule I and II controlled substances.
We also developed the regulatory impact analysis (RIA), the initial and final regulatory flexibility analyses (IRFA, FRFA), and the information collection requests (ICRs). ICF has assisted in DEA’s reorganizing and redrafting of all its rules (21 CFR parts 1300-1316) into plain language. In addition to regulatory support, ICF has advised DEA on its internal processes for managing its regulatory program and capturing institutional knowledge.
Related Market + Service Offerings